Assessment of a computer-based treatment for older amblyopes: The Glasgow Pilot Study

Eye

Volumn 23, Issue 1, 2009, Pages 124-131

  Cleary, M ^a   Moody, A D ^b   Buchanan, A ^a   Stewart, H ^a   Dutton, G N ^c  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Amblyopia; Binocular treatment; Suppression; Virtual reality

Indexed keywords

AMBLYOPIA; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERACTIVE BINOCULAR TREATMENT SYSTEM; MALE; PRESCHOOL CHILD; SCHOOL CHILD; VIRTUAL REALITY; VISUAL ACUITY;

EID: 58249097158     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702977     Document Type: Article

References (37)

1. Attebo K, Mitchell P, Cumming R, Smith W, Jolly N, Sparkes R. Prevalence and causes of amblyopia in an adult population. Ophthalmology 1998; 105: 154-159.
2. Royal College of Ophthalmology guidelines on strabismus and amblyopia 2006. http://www.rcophth.ac.uk/docs/scientific/ ListofPublished&PendingGuidelinesJanuary2006.pdf.
3. Stewart CE, Moseley MJ, Fielder AR, Stephens DA, MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2004; 88(12): 1552-1556.
4. Newsham D. Parental non-concordance with occlusion therapy. Br J Ophthalmol 2000; 84(9): 957-962.
5. Loudon SE, Polling JR, Simonsz HJ. A preliminary report about the relation between visual acuity increase and compliance in patching therapy for amblyopia. Strabismus 2002; 10(2): 79-82.
6. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci 2005; 46(4): 1435-1439.
7. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci 2005; 46(9): 3152-3160.
8. Smith LK, Thompson JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995; 32(2): 98-101.
9. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as a primary treatment for amblyopia. Br J Ophthalmol 1997; 81: 54-57.
10. Beardsell R, Clarke S, Hill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophthalmol Strabismus 1999; 36(1): 19-24.
11. Oto S, Pelit A, Aydin P. Non-concordance in amblyopia treatment: the effective use of 'smileys'. Strabismus 2002; 10(1): 23-30.
12. Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 2002; 16(2): 150-155.
13. Loudon SE, Polling JR, Simonsz HJ. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase. Graefes Arch Clin Exp Ophthalmol 2003; 241(3): 176-180.
14. Chua B, Johnson K, Martin F. A retrospective review of the associations between amblyopia type, patient age, treatment compliance and referral patterns. Clin Experiment Ophthalmol 2004; 32(2): 175-179.
15. Packwood EA, Cruz OA, Rychwalski PJ, Keech RV. The psychosocial effects of amblyopia study. J AAPOS 1999; 3(1): 15-17.
16. Cole SR, Beck RW, Moke PS, Celano MP, Drews CD, Repka MX, et al., Pediatric eye disease investigator group. The amblyopia treatment index. J AAPOS 2001; 5(4): 250-254.
17. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified? Br J Ophthalmol 2000; 82(6): 572-578.
18. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the monitored occlusion treatment of amblyopia study (MOTAS). Invest Ophthalmol Vis Sci 2004; 45(9): 3048-3054.
19. Tan JH, Thompson JR, Gottlob I. Differences in the management of amblyopia between European countries. Br J Ophthalmol 2003; 87(3): 291-296.
20. Eastgate RM, Griffiths GD, Waddingham PE, Moody AD, Butler TK, Cobb SV et al. Modified virtual reality technology for treatment of amblyopia. Eye 2006; 20(3): 370-374.
21. Waddingham PE, Butler TK, Cobb SV, Moody AD, Comaish IF, Haworth SM et al. Preliminary results from the use of the novel interactive binocular treatment (I-BiTtrade mark) system, in the treatment of strabismic and anisometropic amblyopia. Eye 2006; 20(3): 375-378.
22. McGraw PV, Winn B. Glasgow Acuity Cards: a new test for the measurement of letter acuity. Ophthalmic Physiol Opt 1993; 13: 400-404.
23. Simmers AJ, Gray LS, Spowart K. Screening for amblyopia: a comparison of paediatric letter tests. Br J Ophthalmol 1997; 81(6): 465-469.
24. McGraw PV, Winn B, Gray LS, Elliott DB. Improving the reliability of visual acuity measures in young children. Ophthalmic Physiol Opt 2000; 20: 173-184.
25. Stewart CE, Moseley MJ, Fielder AR. Defining and measuring treatment outcome in unilateral amblyopia. Br J Ophthalmol 2003; 87(10): 1229-1231.
26. Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years compliance cures. Arch Ophthalmol 2000; 118: 1535-1541.
27. Mohan K, Kanwar MS, Saroha V, Vandana MS, Sharma A, Ashok MS. Successful occlusion therapy for amblyopia in 11-15-year-old children. J Pediatr Ophthalmol Strabismus 2004; 41(2): 89-95.
28. Park KH, Hwang JM, Ahn JK. Efficacy of amblyopia therapy initiated after 9 years of age. Eye 2004; 18(6): 571-574.
29. Pediatric Eye Disease Investigator Group. A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol 2004; 137(3): 581-583.
30. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children age 7-17 years. Arch Ophthalmol 2005; 123: 437-447.
31. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121: 603-611.
32. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 110(11): 2075-2087.
33. Arikan G, Yaman A, Berk AT. Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 2005; 13(2): 63-69.
34. Simmers AJ, Gray LS, McGraw PV, Winn B. Functional visual loss in amblyopia and the effect of occlusion therapy. Invest Ophthalmol Vis Sci 1999; 40(12): 2859-2871.
35. Dorey SE, Adams GG, Lee JP, Sloper JJ. Intensive occlusion therapy for amblyopia. Br J Ophthalmol 2001; 85(3): 310-313.
36. Harwerth RS, Fredenburg PM. Binocular vision with primary microstrabismus. Invest Ophthalmol Vis Sci 2003; 44(10): 4293-4306.
37. Grossberg S. Why do parallel cortical systems exist for the perception of static form and moving form? Percept Psychophs 1991; 49(2): 117-141.